Skip to content

Comparison of Customized and Standard Facemasks for Early Treatment of Class III Malocclusion

Comparison of Customized and Standard Facemasks for Early Treatment of Class III Malocclusion: Randomized Crossover Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06402656
Enrollment
24
Registered
2024-05-07
Start date
2024-09-01
Completion date
2026-01-01
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extraoral Traction Appliances, Malocclusion, Angle Class III

Brief summary

The aim of the study is to compare a customized facemask for the treatment of Class III malocclusion in the prepubertal growing patient (patients between the ages of 5 and 12 years) versus a standard commercial facemask. Specifically, preference, pain, difficulty in sleeping, time of use, and possible complications for the two types of facemasks will be analyzed. This is a single-center, national, controlled, superiority, randomized, crossover, open-label study. Each patient will be treated with both the customized facemask and the standard commercial facemask. Each patient will wear one type of facemask for 2 months and the other type of facemask for the next 2 months. After 2 weeks and at the end of therapy with each of the facemask types, the patient, with the possible help of the parents, will have to answer a questionnaire about pain and difficulty sleeping and report any complications. In addition, after completing both phases (fourth month), the patient should indicate a preference for one of the two types of mask with which to complete therapy for an additional 6 months.

Interventions

DEVICECustomized facemask

The customized face mask will be fabricated from a 3D digital image of the patient's face obtained by means of a 3D scanner. Such a scanner consists of 6 digital SLR cameras and software capable of processing a 3-D image of the patient's face exportable as an stl file.

DEVICEStandard facemask

The standard facemask is the commercially available Petit standard facemask

Sponsors

Azienda Ospedaliero-Universitaria Careggi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Age between 5 and 12 years; * Class III malocclusion, for which early orthopedic treatment with rapid maxillary expander and facemask is indicated. * signing of informed consent

Exclusion criteria

* Cleft lip and/or palate. * Craniofacial syndromes.

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire on the preference of the patient for one of the two types of face masks4 monthsThe primary endpoint is a questionnaire on the preference between the two types of face masks at the end of the second phase of therapy (4 months after delivery of the first face mask)

Secondary

MeasureTime frameDescription
Pain reported by patientsAt 2 weeks and at 2 months after delivery of each of the 2 face masksPain measured through Visual Analogue Scale with minimum value of 0 and maximum value of 10. Higher scores mean worse pain.
Difficulty in sleeping reported by patientsAt 2 weeks and at 2 months after delivery of each of the 2 face masksDifficulty in sleeping measured through VAS Visual Analogue Scale with minimum value of 0 and maximum value of 10. Higher scores mean more difficulty in sleeping.
Number of complicationsAt 2 weeks and at 2 months after delivery of each of the 2 face masksNumber of complications
Total time wearAt 2 months after delivery of each of the 2 face masksTotal time wear measured with a thermosensor (Theramon)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026